Moderately hypofractionated definitive radiotherapy may be used as a radical treatment option in patients with inoperable non ...

At two years of follow-up, fewer than 20% of evaluable patients developed grade 2 or higher radiation-related toxic effects, ...

The combination of trabectedin (Yondelis; Pharma Mar, Johnson & Johnson) and olaparib (Lynparza; AstraZeneca, Merck) may be a meaningful treatment for certain patients with advanced soft tissue ...

Against the backdrop of a case report, pembrolizumab was investigated as immunotherapy for undifferentiated pleomorphic soft tissue sarcoma. Noting that immunotherapy for soft tissue sarcoma (STS) has ...

Radiotherapy was associated with an 8.1-fold increased risk of developing a thoracic soft tissue sarcoma in one cohort (95% CI 1.1-60.4, P=0.0052) and 3.0-fold elevated risk in the other (95% CI 2.4-3 ...

Patients with non-metastatic soft tissue sarcoma (STS) who need pre-operative radiation therapy can safely receive hypofractionated treatment over three weeks instead of five, with comparable tumor ...

Please provide your email address to receive an email when new articles are posted on . BOSTON — Excisional biopsies of soft tissue sarcoma of the hand are associated with more positive margins and a ...

Prognostic factors in soft tissue sarcomas encompass a diverse spectrum of clinical, pathological and host-related parameters that influence patient outcomes. Increasingly, research is demonstrating ...

Soft tissue sarcomas (STS) represent a heterogeneous group of extraskeletal mesenchymal tumors that affect individuals throughout the entire age continuum. Despite this pervasive influence, key ...

In a significant new study, UC Davis Comprehensive Cancer Center researchers have uncovered a link between a patient's microbiome and their immune system that can potentially be used to improve the ...

Angiosarcoma is an aggressive malignancy derived from endothelial cells, characterised by its rapid progression, heterogeneity and distinct clinical challenges. As a subset of soft tissue sarcomas, ...

A novel intratumoral treatment was administered to the first patient in a phase 3 trial for certain patients with metastatic soft tissue sarcoma. A phase 3 trial for patients with metastatic soft ...